| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/18/1992 | US5089527 Pentamidine solutions |
| 02/18/1992 | US5089521 Bactericides |
| 02/18/1992 | US5089500 Viricides; hepatitis, aids |
| 02/18/1992 | US5089479 Adhesion of mycoplasma pneumoniae and mycoplasma hominus to sulfatide |
| 02/18/1992 | US5089476 Glutamic acid derivatives |
| 02/18/1992 | US5089475 Administering of growth hormone |
| 02/18/1992 | US5089400 Recombinant DNA which produces lymphoblastoid interferon-like polypeptides, useful as immunomodulators |
| 02/18/1992 | US5089274 Use of bactericidal/permeability increasing protein or biologically active analogs thereof to treat endotoxin-related disorders |
| 02/18/1992 | US5089251 Aromatic derivatives and their use as antimicrobial agents |
| 02/18/1992 | US5089175 Hydroxyalkane carboxylic acid derivatives and their production |
| 02/18/1992 | CA2088926A1 Cephalosporin compounds and processes for preparation thereof |
| 02/18/1992 | CA1295995C Antibacterial compounds, their production and use |
| 02/18/1992 | CA1295944C Pharmaceutical composition with antiviral or antitumor activity |
| 02/17/1992 | WO1992003455A1 INHIBITION OF $i(CANDIDA) |
| 02/17/1992 | CA2089665A1 Inhibition of candida |
| 02/16/1992 | WO1992003563A1 Method for modifying the cell, tissue or host tropism of a microorganism; recombinant microorganisms obtained in this way and use thereof in medicine and veterinary medicine |
| 02/16/1992 | WO1992003051A1 Inhibition of herpesviridae infection by antisense oligonucleotides |
| 02/16/1992 | CA2089484A1 Method for modifying the cell tissue or host tropism of a microorganism; recombinant microorganisms obtained in this way and use thereof in medicine and veterinary medicine |
| 02/16/1992 | CA2089476A1 Inhibition of herpesviridae infection by antisense oligonucleotides |
| 02/15/1992 | WO1992003454A1 Inhibition of influenza virus type a, ann arbor strain h2n2 by antisense oligonucleotides |
| 02/15/1992 | CA2089562A1 Inhibition of influenza virus type a, ann arbor strain h2n2 by antisense oligonucleotides |
| 02/15/1992 | CA2048843A1 Hydrogenated rapamycin derivatives |
| 02/14/1992 | CA2088496A1 Recombinant bpi proteins, uses of bpi proteins, and methods of preparing same |
| 02/14/1992 | CA2048871A1 Immunogenic conjugates of nontoxic oligosaccharide derived from bordetella pertussis lipooligosaccharide |
| 02/14/1992 | CA2048594A1 Embodiments of the hiv principal neutralizing determinant |
| 02/13/1992 | DE4025499A1 Verwendung der antikoerper br55-2, deren derivate, konjugate und fragmente zur bekaempfung von hiv-infektionen Use of antibodies BR55-2, derivatives thereof, and fragments conjugate on HIV infections |
| 02/12/1992 | EP0470804A1 Oxorapamycin |
| 02/12/1992 | EP0470667A1 Composition containing a 4-quinolone derivative complexed with a divalent metal ion |
| 02/12/1992 | EP0470490A1 Substituted pyrroles |
| 02/12/1992 | EP0470431A2 Use of fosfomycin pharmaceutically acceptable salts as a topical cicatrizer |
| 02/12/1992 | EP0470144A1 Beta-hydroxamate d-aspartic acid for treatment of viral infections and tumours. |
| 02/12/1992 | CN1058595A Thioalkylthio cephalosporin derivatives |
| 02/12/1992 | CN1058593A Process and intermediates for beta-lactams having aminothiazole (iminoxyacetic acid) acetic acid sidechains |
| 02/11/1992 | US5087697 Therapeutic nucleosides |
| 02/11/1992 | US5087621 Microbiocides |
| 02/11/1992 | CA1295614C 9-(phosphonylmethoxyalkyl)adenines, the method of preparation and utilization thereof |
| 02/10/1992 | CA2048541A1 Synergistic composition of 2-(2-bromo-2-nitroethenyl) furan and 2-bromo-2-nitropropane-1,3-diol and uses thereof |
| 02/10/1992 | CA2048540A1 42-oxorapamycin |
| 02/06/1992 | WO1992001791A1 Method of preparation of vaccines, and the use of the vaccines thus prepared |
| 02/06/1992 | WO1992001783A1 Dna capable of site-specific integration into mycobacteria |
| 02/06/1992 | WO1992001717A1 Bacterial stress proteins |
| 02/06/1992 | WO1992001713A1 Peptides and analogues and mixtures thereof for detecting antibodies to htlv-i and htlv-ii viruses |
| 02/06/1992 | WO1992001708A1 Vinylsulphonyl pristinamycin and preparation thereof |
| 02/06/1992 | WO1992001696A1 Cephalosporins and homologues, preparations and pharmaceutical compositions |
| 02/06/1992 | WO1992001695A1 Cephalosporins and homologues, preparations and pharmaceutical compositions |
| 02/06/1992 | WO1992001694A1 New salts derived from dialkylaminoalkylsulphonyl-26 pristinamycin ii¿b? |
| 02/06/1992 | WO1992001692A1 Method for preparing sulphonylpristinamycin ii¿b? |
| 02/06/1992 | WO1992001676A1 Quinolonecarboxylic acid derivative |
| 02/06/1992 | WO1992001473A1 Improved immunotherapeutic method of preventing or treating viral respiratory tract disease |
| 02/06/1992 | WO1992001471A1 Methods of use of bovine respiratory syncytial virus recombinant dna, proteins vaccines, antibodies, and transformed cells |
| 02/06/1992 | WO1992001470A1 Target specific antibody-superantigen conjugates and their preparation |
| 02/06/1992 | WO1992001466A1 Prophylactic and therapeutic applications of peroxidases |
| 02/06/1992 | WO1992001460A1 Antigenic iron repressible proteins from n. meningitidis related to the hemolysin family of toxins |
| 02/06/1992 | WO1992001457A1 Products and processes for the treatment of the alimentary canal |
| 02/06/1992 | WO1992001452A1 Enzyme inactivators |
| 02/06/1992 | CA2087853A1 Methods of use of bovine respiratory syncytial virus recombinant dna, proteins vaccines, antibodies, and transformed cells |
| 02/06/1992 | CA2087596A1 Products and processes for the treatment of the alimentary canal |
| 02/06/1992 | CA2087160A1 Antigenic iron repressible proteins from n. meningitidis related to the hemolysin family of toxins |
| 02/06/1992 | CA2087100A1 Immunotherapeutic method of preventing or treating viral respiratory tract disease |
| 02/06/1992 | CA2086923A1 Vinylsulphonyl pristinamycin and preparation thereof |
| 02/05/1992 | EP0470006A1 Thiourea derivatives and antimicrobial agent and antiulcer agent containing the same |
| 02/05/1992 | EP0469983A1 Peroxyacid-clathrates, their preparation and their uses |
| 02/05/1992 | EP0469844A1 2-(9-fluorenonyl)-carbapenem |
| 02/05/1992 | EP0469281A1 Amino acid residue sequence of hepatitis B core antigen |
| 02/05/1992 | EP0469080A1 Method of inhibiting induction of latent or chronic viral infections |
| 02/05/1992 | EP0469036A1 Composition and treatment with biologically active peptides and antibiotic. |
| 02/05/1992 | EP0468998A1 Peptides having novel polar n-terminal groups |
| 02/05/1992 | CN1058399A Piperidyl ethers and thioethers as inhibitors of cholesterol biosynthesis |
| 02/05/1992 | CN1058392A Fungicides |
| 02/04/1992 | WO1992004895A1 Enhancement of glutathione levels with glutamine |
| 02/04/1992 | WO1992002220A1 Tnf inhibitors |
| 02/04/1992 | US5086165 Inhibitors of retroviral protease with a ketomethylene isosteric replaced amide bond |
| 02/04/1992 | US5086051 1H, 3H-pyrrolo[1,2-c]thiazole-7-carboxamide derivatives and pharmaceutical compositions containing them |
| 02/04/1992 | US5085990 Teicoplanin-like derivatives |
| 02/04/1992 | US5085862 Mutants, vaccine; immunoprotective in mice |
| 02/04/1992 | CA2088352A1 Tnf inhibitors |
| 02/03/1992 | WO1992002817A1 Adhesion receptors for pathogenic or opportunistic microorganisms |
| 02/03/1992 | WO1992002628A1 Expression of human cmv glycoprotein-h using the baculovirus-insect cell expression system |
| 02/03/1992 | WO1992002251A1 Herpes simplex virus vp16 vaccines |
| 02/03/1992 | WO1992002231A1 Anti-human immunodeficiency virus agent |
| 02/03/1992 | CA2088599A1 Expression of human cmv glycoprotein-h using the baculovirus-insect cell expression system |
| 02/03/1992 | CA2066155A1 Antiviral agent for human immunodeficiency virus |
| 02/02/1992 | WO1992002518A1 Derivatives of mupirocin |
| 02/02/1992 | WO1992002480A1 Golfomycin derivatives: novel fused ring cyclodecadiyne derivatives |
| 02/02/1992 | WO1992002227A1 Phosphene oxide-terminated allene-ene-yne dna-cleaving, antitumor and antibiotic molecules |
| 02/02/1992 | CA2088505A1 Derivatives of mupirocin |
| 02/02/1992 | CA2088498A1 Golfomycin derivatives: novel fused ring cyclodecadiyne derivatives |
| 02/02/1992 | CA2085599A1 Phosphene oxide-terminated allene-ene-yne dna-cleaving, antitumor and antibiotic molecules |
| 02/02/1992 | CA2048279A1 2-(9-fluorenonyl)-carbapenem |
| 02/02/1992 | CA2048269A1 2-(9-fluorenonyl)-carbapenem antibacterial agents |
| 02/01/1992 | CA2048029A1 Amino acid residue sequence of hepatitis b core antigen |
| 01/31/1992 | WO1992002530A1 Hexa-n-(o-hydroxybenzyl) neomycin b for inhibiting human retroviruses and for the treatment of aids |
| 01/31/1992 | WO1992002497A1 Peroxyacid clathrates, their production and use |
| 01/31/1992 | CA2085367A1 Hiv-transactivators to treat aids |
| 01/31/1992 | CA2066050A1 Peroxyacid clathrates; process for preparing the same and their use |
| 01/30/1992 | DE4023721A1 Modified Gram negative bacteria for use as vaccine and adjuvant - are transformed to express lytic protein or toxin, forming ghost(s) which present many cell wall epitope(s) |
| 01/29/1992 | EP0468866A1 Novel carbocyclic analogs of certain nucleosides |
| 01/29/1992 | EP0468714A2 Peptide-polysaccharide-protein conjugate vaccines |
| 01/29/1992 | EP0468702A2 Novel process for purification of Hepatitis-A virus capsids |
| 01/29/1992 | EP0468683A1 Fungicidal acylamidobenzamides |